Biomed Realty Trust (NYSE: BMR) and New York REIT (NYSE:NYRT) are both financials companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends and valuation.

Profitability

This table compares Biomed Realty Trust and New York REIT’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biomed Realty Trust 18.98% 3.73% 2.07%
New York REIT N/A -5.71% -2.70%

Analyst Recommendations

This is a breakdown of recent ratings for Biomed Realty Trust and New York REIT, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biomed Realty Trust 0 0 0 0 N/A
New York REIT 0 0 1 0 3.00

New York REIT has a consensus target price of $9.75, indicating a potential upside of 26.62%. Given New York REIT’s higher possible upside, analysts clearly believe New York REIT is more favorable than Biomed Realty Trust.

Insider & Institutional Ownership

70.5% of New York REIT shares are owned by institutional investors. 0.1% of New York REIT shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Valuation and Earnings

This table compares Biomed Realty Trust and New York REIT’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio EBITDA Earnings Per Share Price/Earnings Ratio
Biomed Realty Trust N/A N/A N/A N/A N/A
New York REIT $174.99 million 7.39 $52.35 million ($0.50) -15.40

New York REIT has higher revenue and earnings than Biomed Realty Trust.

Summary

New York REIT beats Biomed Realty Trust on 5 of the 8 factors compared between the two stocks.

Biomed Realty Trust Company Profile

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company’s tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company’s properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

New York REIT Company Profile

New York REIT, Inc. is a real estate investment trust. The Company owns a portfolio of commercial real estate. The Company’s business is primarily conducted through New York Recovery Operating Partnership, L.P. As of December 31, 2016, the Company owned 19 properties, which aggregated 3.3 million rentable square feet. The Company holds interests in properties of various types, such as office, retail, hotel, parking and storage. The Company’s properties include Design Center, 416 Washington Street, 50 Varick Street, 1440 Broadway, One Worldwide Plaza, 256 West 38th Street, 229 West 36th Street, 333 West 34th Street, 367-387 Bleecker Street, 33 West 56th Street (garage) and 350 West 42nd Street.

Receive News & Ratings for Biomed Realty Trust Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomed Realty Trust Inc and related companies with MarketBeat.com's FREE daily email newsletter.